Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial

Siri Opsahl Hetlevik, Vibke Lilleby, Maiju Pesonen, Ellen Nordal, Marite Rygg, Cathrine Austad, Maria Karolina Jonsson, Maria Bilstad, Hege Kilander Høiberg, Nina Krafft Sande, Berit Flatø, Siri Lillegraven, Espen A. Haavardsholm, Athimalaipet V. Ramanan, Øyvind Molberg, Pernille Bøyesen, Anna-Birgitte Aga

Open source

DOI
10.1186/s13063-026-09539-0
Published
2026-02-17
Container
Trials
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-026-09539-0,
  title = {Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial},
  author = {Siri Opsahl Hetlevik and Vibke Lilleby and Maiju Pesonen and Ellen Nordal and Marite Rygg and Cathrine Austad and Maria Karolina Jonsson and Maria Bilstad and Hege Kilander Høiberg and Nina Krafft Sande and Berit Flatø and Siri Lillegraven and Espen A. Haavardsholm and Athimalaipet V. Ramanan and Øyvind Molberg and Pernille Bøyesen and Anna-Birgitte Aga},
  year = {2026},
  journal = {Trials},
  doi = {10.1186/s13063-026-09539-0},
  url = {https://doi.org/10.1186/s13063-026-09539-0}
}

RIS

TY  - JOUR
TI  - Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial
AU  - Siri Opsahl Hetlevik
AU  - Vibke Lilleby
AU  - Maiju Pesonen
AU  - Ellen Nordal
AU  - Marite Rygg
AU  - Cathrine Austad
AU  - Maria Karolina Jonsson
AU  - Maria Bilstad
AU  - Hege Kilander Høiberg
AU  - Nina Krafft Sande
AU  - Berit Flatø
AU  - Siri Lillegraven
AU  - Espen A. Haavardsholm
AU  - Athimalaipet V. Ramanan
AU  - Øyvind Molberg
AU  - Pernille Bøyesen
AU  - Anna-Birgitte Aga
PY  - 2026
JO  - Trials
DO  - 10.1186/s13063-026-09539-0
UR  - https://doi.org/10.1186/s13063-026-09539-0
ER  - 

APA

Hetlevik, S. O., Lilleby, V., Pesonen, M., Nordal, E., Rygg, M., Austad, C., Jonsson, M. K., Bilstad, M., Høiberg, H. K., Sande, N. K., Flatø, B., Lillegraven, S., Haavardsholm, E. A., Ramanan, A. V., Molberg, Ø., Bøyesen, P., & Aga, A. (2026). Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial. Trials. https://doi.org/10.1186/s13063-026-09539-0

Source records